Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5983_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
6 Мб
Скачать
☆
198
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

7.1 INTRODUCTION

A drug delivery system (DDS) delivers active pharmaceutical ingredients
      -

        


    Jameson and
     



-


         



         
approved oral tablet Spritam
®
in August 2015, have stimulated the research,

pharmaceutical science.
       
delivery devices. Its advantages include the ability to accurately control the
-
       
      

available on the market makes it possible to use various FDA-approved


       
       -
        


doses.
3D Printed Devices as Drug Delivery Systems
199
  -





7.2 ADDITIVE MANUFACTURING IN PHARMACOLOGY


            
            
   

      
     


    

pharmacology has been able to design 3D-printed drug delivery devices to

A general printing process begins by creating a 3D CAD model through
            
       
as Slicer, Cura, and Makerbot slice the model according to the desired

         





chosen by the operator. Once completed, the G-code provides all the coordi-

printing process, postprocessing can be conducted to enhance the strength


smoothing, and polishing. In drug-loaded systems, postprocessing depends

200
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-


properties (Daminabo et al., 2020).
In recent years, 3D printing has become increasingly popular in pharmaceu-

using this technology (
 
         


    

     
used 3D printing techniques in pharmaceutical science.
FIGURE 7.1 
devices.
3D Printed Devices as Drug Delivery Systems
201

7.2.1 EXTRUSION-BASED 3D PRINTING TECHNIQUES



Algahtani et
al., 2018). Extrusion-based 3D printing involves extruding materials through













 
-

       
  
          
     

        
      
modeling (FDM) and semisolid extrusion (SSE), respectively.

   
commonly used 3D printing methods in pharmacology. In 2009, the patent
       
      Cailleaux et



202
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2


    
       
       
         

completed, the bed or heating head moves perpendicular to the layer plan
 


continues until the last layer is deposited.
   

         
extrusion (HME). Another option is to use postdrug loading techniques,


 
    




           
       



temperature used in SSE processes, it is also possible to extrude live cell-

SSE printing machines typically include a UV light source to permit


    

3D Printed Devices as Drug Delivery Systems
203


  
and blockage. Biomedical researchers are using other methods to design
-
    
and selective laser sintering (SLS).

7.2.2 STEREOLITHOGRAPHY

         
       
-

-
Huang et al., 2020). SLA, consolidated by Hull


   



SLA printers used galvanometric mirrors to control the laser beam along




      

  
       


improved this technique by proposing that multiple mask sets be replaced


-

204
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

7.2.3 SELECTIVE LASER SINTERING




high temperatures and must at least be partially thermostable (
        
 


         



and Dicknes, 2003).

        
         


-



using polycaprolactone (PCL), ethyl cellulose (EC), hydroxypropyl meth-
ylcellulose (HPMC), Eudragit, vinylpyrrolidone-vinyl acetate copolymer
(Kollidon
®
VA 64), and polyethylene oxide (PEO).

7.2.4 BINDER JET PRINTING


          

rollers. Next, a liquid binder (such as a polymer in a colloidal or aqueous




(Paranthaman et al., 2016). Finally, the structure is heated to cure the binder
3D Printed Devices as Drug Delivery Systems
205

      
made mechanically strong.


× 1200 × 600 mm). Such conditions,

          

       

drug delivery.

7.3 MOST COMMON POLYMERS

7.3.1 NATURAL POLYMERS


Cellulose is a biocompatible polysaccharide present in vegetables, cotton-


most organic solvents (Gupta et al., 2021). Its thermoplastic ester derivatives
      
        




biodegradable ether that is nontoxic and resistant at room temperature. Its

systems and tissue engineering (Debnath et al., 2021).


-
patible, soluble in salts and esters, porous, and biodegradable (in vitro and in
vivo environment) (
206
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-
tion, viscosity increases by approximately 20×, and viscosity is inversely
     
-

       

       
a minor component, alginate has been used to modulate the properties
          
   



      





marine animals, microorganisms, and insects (
copolymer approved by the Food and Drug Administration (FDA) and is
-


     
          


      
depends on its structure. Chitosan has excellent viscosity in its non-branched
-

     

         
3D Printed Devices as Drug Delivery Systems
207


       

 -

-

  
bioprinting (layer-by-layer deposition), laser-based bioprinting (such as

  
engineering, drug delivery, household appliances, and tissue engineering. In



7.3.2 SYNTHETIC POLYMERS


    
         
         
 Lyu et al., 2019). In 3D printing,

point (58–60°      
–60°C) and tensile properties (tensile modulus 251–440 MPa, yield strength
  
         

   
         

-

-

 